NCT04933565View on ClinicalTrials.gov

First in Human Study of ORG-129 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

81

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 12, 2022

Study Completion Date

January 9, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

ORG-129

ORG-129 oral capsules

DRUG

Placebo

Placebo oral capsules

Trial Locations (1)

08025

Institut de Recerca de l'Hospital de la Santa Creu i de Sant Pau, Barcelona

Sponsors

Lead Sponsor

Origo Biopharma

All Listed Sponsors

lead

Origo Biopharma

INDUSTRY